Sangamo Therapeutics, Inc. (0R1D.L) LSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 115.97M |
| Enterprise Value | 121.82M |
| P/E Ratio | N/A |
| PEG Ratio | N/A |
| Price/Sales Ratio | N/A |
| Price/Book Ratio | N/A |
| Enterprise/Revenue | N/A |
| Enterprise/EBITDA | N/A |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | N/A |
| Operating Margin | N/A |
AD
Management Effectiveness
| Return On Assets | N/A |
| Return On Equity | N/A |
Income Statement
| Revenue | 39.55M |
| Revenue/Share | N/A |
| Gross Profit | 31.95M |
| EBITDA | -100.4M |
| Net Income | -122.93M |
| Diluted EPS | -0.44 |
Balance Sheet
| Total Cash | 27.59M |
| Total Cash/Share | N/A |
| Total Debt | 19.33M |
| Total Debt/Equity | N/A |
| Current Ratio | N/A |
| Book Value Per Share | N/A |
Price History
| 52-Week Change | -71.47 |
| 52-Week High | 2.11 |
| 52-Week Low | 0.15 |
| Moving Average 50 Days | 0.72 |
| Moving Average 200 Days | 0.81 |
Statistics
| Average Volume | 47,193 |
| Shares Outstanding | 411.73M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | N/A |
| Trailing Annual Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
